End-of-life care quality for American Indians with cancer.

IF 9.9 1区 医学 Q1 ONCOLOGY
Marc A Emerson, Lisa P Spees, Bradford E Jackson, Soroush Fariman, Joel Begay, Hayley N Morris, Ana I Salas, Christopher D Baggett, Tomi Akinyemiju, Ronny A Bell, Stephanie B Wheeler
{"title":"End-of-life care quality for American Indians with cancer.","authors":"Marc A Emerson, Lisa P Spees, Bradford E Jackson, Soroush Fariman, Joel Begay, Hayley N Morris, Ana I Salas, Christopher D Baggett, Tomi Akinyemiju, Ronny A Bell, Stephanie B Wheeler","doi":"10.1093/jnci/djaf007","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>American Indians experience disparities in cancer outcomes. Little is known about the quality of end-of-life care in American Indian patients with cancer.</p><p><strong>Methods: </strong>We retrospectively analyzed end-of-life care for North Carolina patients who died (decedents) diagnosed with any cancer between 2003 and 2018 using the Cancer Information & Population Health Resource. Measures of end-of-life care quality were informed by existing literature and included in-hospital death, hospice use, and other health-care utilization within the last 30 days of life. Associations between race and ethnicity and end-of-life outcomes were evaluated to estimate adjusted risk ratios (RRs). Because within-group heterogeneity can influence health outcomes and intervention effectiveness, we also evaluated associations among American Indian individuals only.</p><p><strong>Results: </strong>We identified 163 285 (1769 American Indian and 161 516 White) decedents. The majority (60%) of American Indian individuals lived in a geographic area characterized by non-federally recognized tribes. American Indian decedents had greater proportions of rural residence than White decedents (54.5% American Indian vs 30.4% White) and dual-Medicaid/Medicare enrollment (37.4% American Indian vs 17.7% White). Compared with White decedents, American Indian decedents had increased hospital admission (adjusted RR = 1.10, 95% confidence interval [CI] = 1.06 to 1.15), intensive care unit admission (adjusted RR = 1.21, 95% CI = 1.11 to 1.32), and more than 1 emergency department visit (adjusted RR = 1.31, 95% CI = 1.20 to 1.44) in the last 30 days of life. We observed statistically significant within-group variation in end-of-life care quality among American Indian patients.</p><p><strong>Conclusions: </strong>Structural barriers to care and rurality may contribute to lower-quality end-of-life care among American Indian decedents compared with White patients. High-quality, culturally appropriate end-of-life care will require a better understanding of care decision-making and access.</p>","PeriodicalId":14809,"journal":{"name":"JNCI Journal of the National Cancer Institute","volume":" ","pages":"1188-1197"},"PeriodicalIF":9.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Journal of the National Cancer Institute","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jnci/djaf007","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: American Indians experience disparities in cancer outcomes. Little is known about the quality of end-of-life care in American Indian patients with cancer.

Methods: We retrospectively analyzed end-of-life care for North Carolina patients who died (decedents) diagnosed with any cancer between 2003 and 2018 using the Cancer Information & Population Health Resource. Measures of end-of-life care quality were informed by existing literature and included in-hospital death, hospice use, and other health-care utilization within the last 30 days of life. Associations between race and ethnicity and end-of-life outcomes were evaluated to estimate adjusted risk ratios (RRs). Because within-group heterogeneity can influence health outcomes and intervention effectiveness, we also evaluated associations among American Indian individuals only.

Results: We identified 163 285 (1769 American Indian and 161 516 White) decedents. The majority (60%) of American Indian individuals lived in a geographic area characterized by non-federally recognized tribes. American Indian decedents had greater proportions of rural residence than White decedents (54.5% American Indian vs 30.4% White) and dual-Medicaid/Medicare enrollment (37.4% American Indian vs 17.7% White). Compared with White decedents, American Indian decedents had increased hospital admission (adjusted RR = 1.10, 95% confidence interval [CI] = 1.06 to 1.15), intensive care unit admission (adjusted RR = 1.21, 95% CI = 1.11 to 1.32), and more than 1 emergency department visit (adjusted RR = 1.31, 95% CI = 1.20 to 1.44) in the last 30 days of life. We observed statistically significant within-group variation in end-of-life care quality among American Indian patients.

Conclusions: Structural barriers to care and rurality may contribute to lower-quality end-of-life care among American Indian decedents compared with White patients. High-quality, culturally appropriate end-of-life care will require a better understanding of care decision-making and access.

美国印第安人癌症患者的临终关怀质量。
背景:美国印第安人(AI)在癌症结局方面存在差异。人们对AI癌症患者的临终关怀质量知之甚少。方法:我们使用癌症信息和人口健康资源,回顾性分析2003-2018年北卡罗来纳州诊断为任何癌症的死亡(死者)患者的EOL护理。EOL照护质量的测量依据现有文献,包括生命最后30天内的院内死亡、安宁疗护使用和其他医疗保健利用。评估种族/民族与EOL结果之间的关系,以估计调整风险比(aRRs)。由于组内异质性会影响健康结果和干预效果,我们也仅评估了AI个体之间的关联。结果:我们确定了163285例(1769例AI和161516例White)的后代。大多数人工智能(60%)生活在以非联邦承认的部落为特征的地理区域。人工智能遗属的农村居民比例高于白人遗属(54.5%的人工智能对30.4%的白人)和双重医疗补助/医疗保险登记(37.4%的人工智能对17.7%的白人)。与白人患者相比,AI患者住院率(aRR, 1.10, 95%可信区间[CI], 1.06-1.15)、ICU住院率(aRR, 1.21;95% CI, 1.11-1.32)和bbb1 ED就诊(aRR, 1.31;95% CI, 1.20-1.44)。我们观察到AI患者EOL护理质量的组内显著差异。结论:与白人患者相比,护理的结构性障碍和农村因素可能导致AI患者的EOL护理质量较低。高质量、符合文化的EOL护理需要更好地理解护理决策和获取途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
17.00
自引率
2.90%
发文量
203
审稿时长
4-8 weeks
期刊介绍: The Journal of the National Cancer Institute is a reputable publication that undergoes a peer-review process. It is available in both print (ISSN: 0027-8874) and online (ISSN: 1460-2105) formats, with 12 issues released annually. The journal's primary aim is to disseminate innovative and important discoveries in the field of cancer research, with specific emphasis on clinical, epidemiologic, behavioral, and health outcomes studies. Authors are encouraged to submit reviews, minireviews, and commentaries. The journal ensures that submitted manuscripts undergo a rigorous and expedited review to publish scientifically and medically significant findings in a timely manner.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信